BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 29
• 30

• Business

  Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer

  December 2, 2008

   · 

  2 min read
• Biotech Bay

  Cytokinetics, Inc. Announces Clinical Trial Data Regarding SB-743921 to Be Presented at the 2008 American Society of Hematology Annual Meeting and Exposition

  December 2, 2008

   · 

  1 min read
• Business

  BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development

  December 2, 2008

   · 

  3 min read
• Business

  Delcath Systems, Inc. Adds University of Pittsburgh Medical Center to Phase III Trial

  December 2, 2008

   · 

  4 min read
• Drug Development

  Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints

  December 2, 2008

   · 

  5 min read
• Biotech Beach

  Sequenom Inc. Release: Next-Generation Noninvasive Diagnostic Technology Shown to Accurately Detect Fetal Down Syndrome in First Trimester of Pregnancy

  December 2, 2008

   · 

  1 min read
• Business

  NeuralStem Inc. Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials

  December 2, 2008

   · 

  3 min read
• BioMidwest

  Cook Medical Improves Patient Care and Changes Economics for Healthcare Providers with Field-Proven Resonance(R) Metallic Ureteral Stent

  December 2, 2008

   · 

  1 min read
• Drug Development

  NPS Pharmaceuticals, Inc. Initiates Phase 3 ‘STEPS’ Study to Confirm GATTEX(TM) Reduces Parenteral Nutrition Dependence in Short Bowel Syndrome

  December 2, 2008

   · 

  1 min read
• Biotech Bay

  Intradigm Corporation Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics Zamore Patent Covers Methods for Enhancing RNAi Structural Features and Strengthens Intradigm’s Competitive Position

  December 2, 2008

   · 

  3 min read